Definition
POI (also called premature menopause or primary ovarian insufficiency) means the ovaries stop working normally before age 40 — periods become irregular or stop, estrogen falls and FSH rises. People with POI may still have intermittent ovarian activity and a small chance of spontaneous pregnancy.
Prevalence / How common
| Region | Typical estimate (approx.) | Notes / sources |
| United Kingdom | ~1 in 100 (≈1%) before age 40 | Cited by NICE / UK sources. |
| United States | ~1% (some studies 1–2%; iatrogenic causes increase numbers) | CDC & clinical reviews; ASRM notes non-iatrogenic estimates may range higher in some series. |
| Europe | ~1% overall; some regional study variation | ESHRE guideline and European reviews. |
| Asia & Africa | Data variable; commonly reported 0.1–1% but study methods differ | Studies show geographic variation and likely under-ascertainment in low-resource settings. |
| Bottom line: POI affects roughly 1% of people under 40 worldwide, but reported rates vary by study methods and whether surgical/medical (iatrogenic) causes are included. |
Causes of POI
- Genetic Factors
- What it means: Abnormalities in genes or chromosomes can cause the ovaries to stop working early. Common examples include Turner syndrome (missing or incomplete X chromosome) or Fragile X syndrome (FMR1 gene mutation).
- Source: ESHRE, ACOG, RCOG, and TOG highlight genetic causes in 20-30% of cases. NICE notes Turner syndrome and Fragile X as key examples.
- Autoimmune Disorders
- What it means: The immune system mistakenly attacks the ovaries, stopping them from producing eggs or hormones. This can be linked to other autoimmune conditions like thyroid disease or Addison’s disease.
- Source: RCOG, ESHRE, and ACOG identify autoimmune causes in 4-30% of cases. NICE mentions associations with autoimmune conditions. TOG notes anti-ovarian antibodies in some cases.
- Iatrogenic Causes (Medical Treatments)
- What it means: Treatments like chemotherapy, radiation therapy (especially pelvic), or ovarian surgery (e.g., for endometriosis or cysts) can damage the ovaries, leading to POI.
- Source: NICE, RCOG, ESHRE, and ACOG list these as common causes, particularly chemotherapy drugs like cyclophosphamide. TOG emphasizes surgical removal of ovarian tissue as a risk.
- Infections
- What it means: Certain infections, like mumps or tuberculosis, can harm the ovaries, though this is rare.
- Source: ESHRE and ACOG note infections as a less common cause. RCOG and NICE mention mumps as a possible trigger. TOG references rare infectious causes.
- Environmental or Toxin Exposure
- What it means: Exposure to toxins like chemicals, pesticides, or cigarette smoke may damage ovarian function, though evidence is limited.
- Source: ESHRE and ACOG list environmental factors as possible contributors. RCOG and NICE mention toxins but note weak evidence. TOG does not emphasize this.
- Metabolic Disorders
- What it means: Rare conditions like galactosemia (a problem processing certain sugars) can affect ovarian function.
- Source: ESHRE and ACOG mention galactosemia as a rare cause. RCOG and NICE note metabolic disorders briefly. TOG does not focus on this.
- Idiopathic (Unknown Cause)
- What it means: In most cases, no clear cause is found despite testing, and the reason for early ovarian failure remains unknown.
- Source: ESHRE, ACOG, and RCOG stress that idiopathic POI is the most common category, affecting 60-90% of cases. NICE and TOG confirm this.
Key Points
- Multifactorial and Often Unclear: POI usually results from a mix of factors, but the cause is unidentified in most cases (ESHRE, ACOG).
- Risk Factors: Family history of POI, autoimmune diseases, or prior cancer treatments increase risk (RCOG, NICE).
- Diagnosis Needed: Testing (e.g., genetic screening, hormone levels) is crucial to identify causes where possible (NICE, ESHRE).
Key symptoms / common presentation
• Irregular periods (oligomenorrhoea) or cessation of periods (amenorrhoea).
• Typical menopausal symptoms: hot flushes, night sweats, vaginal dryness.
• Fertility problems (difficulty conceiving).
• Fatigue, low mood, and possible sexual dysfunction.
• Some people present after chemotherapy / surgery (iatrogenic POI).
Long-term consequences
• Low bone density / osteoporosis (due to estrogen deficiency).
• Increased cardiovascular risk markers (long-term care needed).
• Infertility or reduced fertility (intermittent ovarian activity means pregnancy is still possible but less likely).
• Psychological impact: anxiety, depression, grief, sexual health effects.
• Association with autoimmune disease and genetic causes in some cases — requires broader medical review.
Investigations (how POI is diagnosed)
1. Clinical history & exam — menstrual pattern, family history, prior chemo/radiation, autoimmune disease.
2. Blood tests (confirmatory): raised FSH on at least two occasions (weeks apart) with low estradiol in a person under 40. Also check thyroid, prolactin, androgens as required.
3. Karyotype and Fragile X testing (in younger patients or where family history suggests genetic cause).
4. Autoimmune screening if suspected (e.g., anti-adrenal/thyroid antibodies).
5. Pelvic ultrasound for ovarian volume / antral follicle count if fertility assessment needed.
6. Fertility assessment and discussion of fertility preservation if iatrogenic risk (e.g., before cancer treatment).
Treatment & management (plain language summary)
Goals: replace sex steroids for bone/heart protection and symptom control, address fertility desires, and manage psychological impacts.
1. Hormone replacement (HRT / sex steroid replacement)
• Offer estrogen replacement (combined with progestogen if uterus present) until at least the usual menopausal age (~51) unless contraindicated — to protect bone and cardiovascular health and relieve symptoms. NICE and RCOG recommend offering HRT or combined hormonal contraception.
2. Fertility options
• Discuss spontaneous pregnancy possibility (small, intermittent chance).
• Assisted reproductive techniques (IVF, donor eggs) often required for many who want children. Fertility preservation (egg or embryo freezing) should be offered before gonadotoxic treatments.
3. Bone and cardiovascular risk management
• Calcium & vitamin D where indicated, baseline bone density (DEXA) and monitoring; lifestyle (weight-bearing exercise, stop smoking). Consider bone-protective strategies.
4. Screen for and manage associated conditions
• Autoimmune disease, thyroid disease, adrenal insufficiency (if antibodies present), mental-health support and sexual health.
5. Psychological & practical support
• Offer counselling, peer support groups, and clear information about fertility and long-term health. Multidisciplinary care is best.
Practical points & red flags
• POI is different from natural menopause (occurs <40) and from temporary amenorrhoea — needs investigation.
• If you’re under 40 with irregular/absent periods or menopausal symptoms, ask for FSH/estradiol testing.
• If POI is diagnosed, HRT is usually recommended to reduce long-term health risks unless contraindicated.
Remember, ALWAYS consult with your GP and/or your gynecologist for your specific treatment options. Every woman is different!
Leave a Reply